Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
This study is ongoing, but not recruiting participants.
Study NCT00557557   Information provided by University of Pittsburgh

First Received on November 13, 2007.   Last Updated on September 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Liver Metastases
Additional conditions recognized in this trial
Liver Neoplasms
Neoplasm Metastasis
Neoplasms, Second Primary
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Liver Diseases
Neoplasms
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Interventions listed in this trial
Drug: 5-FU
Drug: Oxaliplatin
Additional drug interventions recognized in this trial
Fluorouracil
Oxaliplatin
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of Pittsburgh
National Institutes of Health (NIH)
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services